• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西方国家与东方国家骨髓增生异常综合征流行病学的差异:种族差异还是环境影响?

Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?

作者信息

Kuendgen Andrea, Matsuda Akira, Germing Ulrich

机构信息

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany.

出版信息

Leuk Res. 2007 Jan;31(1):103-4. doi: 10.1016/j.leukres.2006.03.007. Epub 2006 Apr 19.

DOI:10.1016/j.leukres.2006.03.007
PMID:16630658
Abstract

Myelodysplastic syndromes show ethnic differences. Several investigators have reported a striking difference in age at diagnosis between Eastern and Western MDS patients. Referring to a letter bei Paydas speculating about toxic environmental influences as a possible cause for younger age in Asian MDS patients, we discuss our experience from a direct comparison of Japanese and German MDS, in particular refractory anemia patients.

摘要

骨髓增生异常综合征存在种族差异。几位研究者报告称,东西方骨髓增生异常综合征患者的诊断年龄存在显著差异。针对Paydas的一封信中推测有毒环境影响可能是亚洲骨髓增生异常综合征患者年龄较轻的原因,我们讨论了对日本和德国骨髓增生异常综合征患者,尤其是难治性贫血患者进行直接比较的经验。

相似文献

1
Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?西方国家与东方国家骨髓增生异常综合征流行病学的差异:种族差异还是环境影响?
Leuk Res. 2007 Jan;31(1):103-4. doi: 10.1016/j.leukres.2006.03.007. Epub 2006 Apr 19.
2
No increase in age-specific incidence of myelodysplastic syndromes.骨髓增生异常综合征的年龄特异性发病率无增加。
Haematologica. 2004 Aug;89(8):905-10.
3
Myelodysplastic syndromes: incidence and survival in the United States.骨髓增生异常综合征:美国的发病率与生存率
Cancer. 2007 Apr 15;109(8):1536-42. doi: 10.1002/cncr.22570.
4
Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.2005-2006 年,华盛顿州西部地区非营利性医疗机构中骨髓增生异常综合征的发病率。
Am J Hematol. 2010 Oct;85(10):765-70. doi: 10.1002/ajh.21828.
5
Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998.
Haematologica. 2003 Oct;88(10):1197-9.
6
Epidemiology of myelodysplastic syndromes.骨髓增生异常综合征的流行病学
Semin Hematol. 2008 Jan;45(1):8-13. doi: 10.1053/j.seminhematol.2007.10.003.
7
Young age MDS: differences between Western and Eastern countries.年轻患者骨髓增生异常综合征:东西方国家之间的差异。
Leuk Res. 2006 Mar;30(3):362. doi: 10.1016/j.leukres.2005.07.005. Epub 2005 Aug 24.
8
The epidemiology of myelodysplastic syndromes.骨髓增生异常综合征的流行病学。
Hematol Oncol Clin North Am. 2010 Apr;24(2):287-94. doi: 10.1016/j.hoc.2010.02.011.
9
Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.骨髓增生异常综合征:德国当前医疗护理的各个方面及经济考量
Onkologie. 2008 Sep;31(8-9):477-84. doi: 10.1159/000142900. Epub 2008 Jul 31.
10
Myelodysplastic syndromes: more prevalent than we know.骨髓增生异常综合征:比我们所知的更为普遍。
Geriatrics. 2008 Nov;63(11):10-7.

引用本文的文献

1
Clinical, Hematological, and Cytogenetic Profile of Myelodysplastic Syndromes in Adults: A Three-year Cross-sectional Study.成人骨髓增生异常综合征的临床、血液学和细胞遗传学特征:一项为期三年的横断面研究。
Oman Med J. 2023 Mar 31;38(2):e478. doi: 10.5001/omj.2023.55. eCollection 2023 Mar.
2
How we treat primary immune thrombocytopenia in adults.成人原发免疫性血小板减少症的治疗方法。
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
3
Chinese guidelines for treatment of adult primary immune thrombocytopenia.成人原发性免疫性血小板减少症中国治疗指南。
Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.
4
Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Center in India.骨髓增生异常综合征的临床病理谱及新型核型发现:印度三级医疗中心的经验
Mediterr J Hematol Infect Dis. 2017 Aug 16;9(1):e2017048. doi: 10.4084/MJHID.2017.048. eCollection 2017.
5
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.长崎原子弹辐射所致骨髓增生异常综合征患者的临床特征及预后
Cancer Sci. 2016 Oct;107(10):1484-1491. doi: 10.1111/cas.13025. Epub 2016 Sep 2.
6
Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience.86例中国原发性骨髓增生异常综合征伴8号染色体三体患者的临床预后因素:单中心经验
Yonsei Med J. 2016 Mar;57(2):358-64. doi: 10.3349/ymj.2016.57.2.358.
7
Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems.骨髓增生异常综合征预后评分系统的比较
Turk J Haematol. 2016 Jun 5;33(2):119-26. doi: 10.4274/tjh.2014.0455. Epub 2015 Aug 6.
8
The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.类别、细胞病理学和细胞遗传学对遗传性骨髓衰竭综合征中克隆性和恶性髓系转化的发生发展及进程的影响。
Haematologica. 2015 May;100(5):633-42. doi: 10.3324/haematol.2014.117457. Epub 2015 Feb 14.
9
Prospective analysis of clinical and cytogenetic features of 435 cases of MDS diagnosed using the WHO (2001) classification: a prognostic scoring system for predicting survival in RCMD.采用 WHO(2001)分类标准诊断的 435 例 MDS 患者的临床和细胞遗传学特征的前瞻性分析:预测 RCMD 患者生存的预后评分系统。
Int J Hematol. 2009 Oct;90(3):361-369. doi: 10.1007/s12185-009-0403-5. Epub 2009 Aug 29.